TrumpRx.gov, the federal government’s discount drug website, lists Zepbound at “starting at $299” a month, set against a $1,087 original price, under a heading that reads “Lowest Presidential Deal.” That is the cash price for Eli Lilly’s weight-loss injection sold as a vial, and it shows up as a flat figure on the site’s front page. The product page puts a floor under it: $299 is where the price starts, and the page says the price depends on the strength chosen. Prices for the higher doses are not shown on the page.
The listing matters most to patients who pay cash for Zepbound because insurance does not cover it, or who are weighing whether to keep paying a high copay. The same front page lists the Wegovy pill at $149 a month against $1,349, the Wegovy pen at $199 against the same $1,349, and Ozempic at $199 against $1,028. Zepbound shows the smallest dollar discount of the four, $788 a month, against $829 for Ozempic and $1,150 or more for Wegovy.
The Zepbound page shows no end date and says “Last updated unavailable,” so a change to the $299 starting price would arrive without a notice.
Get the deadline alerts before they pass →
What the $299 covers on the Zepbound page
The Zepbound product page on TrumpRx lists a single form, the vial, in six strengths from 2.5 milligrams to 15 milligrams. It reads “Starting at $299.00” and “Up to 72% off,” a figure that matches $299 against $1,087. Eli Lilly runs the ordering: the page says the company “manages all Zepbound (Tirzepatide) Vial orders through LillyDirect,” and the “Get Started” button hands the customer to that site. Lilly’s customer care line is 844-559-3471, open weekdays 9 a.m. to 7 p.m. Eastern time.
The page calls $299 an out-of-pocket price and adds that anyone with insurance should “check your co-pay first,” because it “may be even lower.” Eligibility is required and terms and conditions apply. The front page, TrumpRx.gov, shows no dates and does not say who set the original prices. The site credits the White House on social media and names a design studio for the build, but it does not name an agency or official responsible for the price list.
How $299 compares with Lilly’s own vial prices
The $299 figure has a history. When Lilly cut its Zepbound vial prices on LillyDirect on December 1, 2025, BioSpace reported the new monthly prices as $299 for the 2.5-milligram starter dose, $399 for 5 milligrams, and $449 for 7.5, 10, 12.5 and 15 milligrams, down from $349 and $499. The 2.5-milligram dose is a starter dose only. If those prices still hold, TrumpRx’s $299 matches the lowest rung on Lilly’s own list, and it does not apply to every dose.
The White House described the same range when TrumpRx opened. In a February 6, 2026 release on President Donald Trump’s unveiling of the site, the administration said the monthly price of Zepbound falls from $1,088 to an average of $346 and as low as $299, depending on dosage. A monthly price that averages $346 sits $47 above the starting price, so a patient moving up through the doses could pay more than the figure on the front page. The TrumpRx product page does not list the per-strength prices.
Who decides what counts as the original price
The $1,087 on the front page and the $1,088 in the White House release are two versions of the same list-price comparison, off by a dollar. Both come from the government’s side of the ledger. Nothing on the TrumpRx page says where the original price comes from, whether it is Lilly’s list price or an average of what pharmacies charge, or whether any patient pays it. Lilly was already selling Zepbound vials to cash buyers on LillyDirect at prices that started at $299 in December 2025.
“Lowest Presidential Deal” is the site’s own label for the discounted column. It carries no legal meaning on the page and no price guarantee. The page lists no start or end date for the price, and it states “Last updated unavailable.” A price that can change without a posted date is worth treating as a snapshot, which is why the dose and date on any quote matter as much as the dollar figure.
Checking the Zepbound price before ordering
The free route is the Zepbound page on TrumpRx itself, which shows the starting price and sends orders to LillyDirect. The price that matters is the one shown at checkout for the prescribed strength, because the 2.5-milligram vial that costs $299 is a starter dose and the page does not list what the other five strengths cost.
The page’s own advice is to look up the insurance copay first, since an insured patient’s copay “may be even lower” than $299. A pharmacist or the plan’s member line can say what the copay would be for the dose a doctor prescribes.
The comparison to watch is the one between the strength that is prescribed and the one that is listed. Lilly’s December 2025 vial prices ran from $299 to $449 a month by dose, and the White House’s own average of $346 falls inside that range. If those December prices still hold, every month on a higher dose costs more than the $299 on the front page, and the TrumpRx page does not say by how much.
More Financial Reading
- 24 Ways to Stretch a $2,087 Social Security Check
- 17 Places to Find Your Share of the $4.25 Billion States Give Back
- 16 Steps to Stop the Scams That Took $7.7 Billion From Seniors
This article was produced with AI assistance and reviewed by The Money Overview’s editorial team.
